8-K Announcements
6Material company update
May 15, 2026·SEC
Material company update
May 12, 2026·SEC
Material company update
Apr 15, 2026·SEC
Stereotaxis, Inc.(STXS)Earnings, Financials & Key Ratios
STXS•AMEX
Price updated Jun 19, 2026
AboutStereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.Show more
- Revenue$32M+20.3%
- EBITDA-$21M+13.5%
- Net Income-$22M+10.0%
- EPS (Diluted)-0.25+16.7%
- Gross Margin52.73%-2.7%
- EBITDA Margin-63.49%+28.1%
- Operating Margin-68.3%+25.7%
- Net Margin-66.85%+25.2%
- ROE-143.55%+0.4%
STXS Key Insights
Stereotaxis, Inc. (STXS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Profits declining 26.6% over 5 years
- ✗Negative free cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when STXS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
STXS Price & Volume
Stereotaxis, Inc. (STXS) stock price & volume — 10-year historical chart
Loading chart...
STXS Growth Metrics
Stereotaxis, Inc. (STXS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-1.5%
5 Years3.99%
3 Years4.78%
TTM13.4%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM14.51%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM20.97%
Return on Capital
10 Years-47.62%
5 Years-61.77%
3 Years-78.94%
Last Year-80.39%
STXS Recent Earnings
Stereotaxis, Inc. (STXS) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
May 12, 2026Metric
Actual
Est
EPS
$0.03+25.0%
$0.04
Rev
$6M-26.0%
$9M
Q2 2026
Mar 9, 2026Metric
Actual
Est
EPS
$0.06+0.0%
$0.06
Rev
$9M-4.8%
$9M
Q4 2025
Nov 11, 2025Metric
Actual
Est
EPS
$0.03+50.0%
$0.06
Rev
$7M-19.2%
$9M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.05+28.6%
$0.07
Rev
$9M+4.3%
$8M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.03vs $0.04+25.0% | $6Mvs $9M-26.0% |
| Q2 2026 | Mar 9, 2026 | $0.06vs $0.06+0.0% | $9Mvs $9M-4.8% |
| Q4 2025 | Nov 11, 2025 | $0.03vs $0.06+50.0% | $7Mvs $9M-19.2% |
| Q3 2025 | Aug 7, 2025 | $0.05vs $0.07+28.6% | $9Mvs $8M+4.3% |
Based on last 12 quarters of dataView full earnings history →
STXS Peer Comparison
Stereotaxis, Inc. (STXS) competitors in Robotic and computer-assisted surgery — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ISRG | 144.48B | 406.78 | 51.69 | 20.51% | 28.15% | 16.89% | 0.02 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 ABT | 153.68B | 88.38 | 11.57 | 4.59% | 31.88% | 27.26% | 0.32 | |
 BSX | 67.31B | 45.29 | 23.35 | 19.87% | 14.4% | 12.4% | 0.51 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 | |
 IRTC | 3.44B | 104.65 | -75.29 | 26.24% | -3.53% | -20.6% | 4.79 | |
 ATRC | 1.46B | 28.80 | -120 | 14.88% | -0.83% | -0.95% | 0.18 | |
 BEAT | 26.16M | 0.76 | -1.23 | -10.34% |
Compare STXS vs Peers
Stereotaxis, Inc. (STXS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
STXS Income Statement
Stereotaxis, Inc. (STXS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 31.14M | 29.35M | 28.9M | 26.63M | 35.02M | 28.15M | 26.77M | 26.92M | 32.38M | 31.2M |
Revenue Growth % | -3.17% | -5.77% | -1.51% | -7.86% | 31.51% | -19.63% | -4.89% | 0.55% | 20.28% | 13.4% |
Cost of Goods Sold | 10.75M | 5.72M | 6.14M | 7.66M | 11.79M | 9.68M | 11.91M | 12.32M | 15.31M | 14.39M |
COGS % of Revenue | 34.53% | 19.48% | 21.23% | 28.78% | 33.66% | 34.38% | 44.49% | 45.78% | 47.27% | - |
Gross Profit | 20.39M▲ 0% | 23.63M▲ 15.9% | 22.77M▼ 3.7% | 18.97M▼ 16.7% | 23.23M▲ 22.5% | 18.47M▼ 20.5% | 14.86M▼ 19.5% | 14.59M▼ 1.8% | 17.07M▲ 17.0% | 16.8M▲ 0% |
Gross Margin % | 65.47% | 80.52% | 78.77% | 71.22% | 66.34% | 65.62% | 55.51% | 54.22% | 52.73% | 53.86% |
Gross Profit Growth % | -17.23% | 15.89% | -3.65% | -16.69% | 22.49% | -20.5% | -19.55% | -1.79% | 16.97% | - |
Operating Expenses | 26.31M | 26.09M | 27.59M | 25.68M | 36.12M | 37.25M | 36.7M | 39.33M | 39.18M | 38.16M |
OpEx % of Revenue | 84.48% | 88.89% | 95.47% | 96.43% | 103.14% | 132.33% | 137.08% | 146.12% | 121.02% | - |
Selling, General & Admin | 21.55M | 17.87M | 18.57M | 17.54M | 25.92M | 26.69M | 26.43M | 29.57M | 30.29M | 30.03M |
SG&A % of Revenue | 69.19% | 60.88% | 64.26% | 65.88% | 74.02% | 94.82% | 98.71% | 109.86% | 93.56% | - |
Research & Development | 4.76M | 8.22M | 9.02M | 8.14M | 10.2M | 10.56M | 10.27M | 9.76M | 9.38M | 9.43M |
R&D % of Revenue | 15.29% | 28.01% | 31.21% | 30.56% | 29.12% | 37.51% | 38.37% | 36.26% | 28.98% | - |
Other Operating Expenses | 212.03K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -492K | -1.29M |
Operating Income | -5.92M▲ 0% | -2.46M▲ 58.5% | -4.83M▼ 96.5% | -6.71M▼ 39.1% | -12.89M▼ 92.0% | -18.78M▼ 45.7% | -21.84M▼ 16.3% | -24.74M▼ 13.3% | -22.11M▲ 10.6% | -21.36M▲ 0% |
Operating Margin % | -19.01% | -8.37% | -16.7% | -25.21% | -36.8% | -66.71% | -81.58% | -91.91% | -68.3% | -68.49% |
Operating Income Growth % | 7.89% | 58.49% | -96.45% | -39.09% | -91.96% | -45.69% | -16.31% | -13.28% | 10.62% | - |
EBITDA | -5.17M | -1.88M | -4.7M | -6.59M | -12.78M | -18.35M | -21.24M | -23.77M | -20.56M | -19.77M |
EBITDA Margin % | -16.59% | -6.4% | -16.28% | -24.74% | -36.5% | -65.18% | -79.35% | -88.31% | -63.49% | -63.38% |
EBITDA Growth % | 11.84% | 63.65% | -150.48% | -40.04% | -94.03% | -43.54% | -15.79% | -11.89% | 13.52% | 20.03% |
D&A (Non-Cash Add-back) | 753.68K | 579.02K | 122.74K | 126.21K | 106K | 429K | 595K | 969K | 1.55M | 1.59M |
EBIT | -5.92M | -2.46M | -4.83M | -6.71M | -12.89M | -18.78M | -21.84M | -24.74M | -22.11M | -21.12M |
Net Interest Income | -179.84K | -16.57K | 235.57K | 67.36K | -10.07K | 484K | 1.1M | 694K | 467K | 486K |
Interest Income | 0 | 0 | 235.57K | 67.36K | 0 | 484K | 1.1M | 694K | 467K | 486K |
Interest Expense | 179.84K | 16.57K | 0 | 0 | 10.07K | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | 32.19K | 2.57M | 235.57K | 67.36K | 2.17M | 484K | 1.13M | 694K | 469K | -317K |
Pretax Income | -5.89M▲ 0% | 116.76K▲ 102.0% | -4.59M▼ 4032.4% | -6.65M▼ 44.8% | -10.72M▼ 61.2% | -18.29M▼ 70.7% | -20.71M▼ 13.2% | -24.05M▼ 16.1% | -21.64M▲ 10.0% | -21.68M▲ 0% |
Pretax Margin % | -18.9% | 0.4% | -15.89% | -24.96% | -30.6% | -64.99% | -77.37% | -89.33% | -66.85% | -69.5% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -5.89M▲ 0% | 116.76K▲ 102.0% | -4.59M▼ 4032.4% | -6.65M▼ 44.8% | -10.72M▼ 61.2% | -18.29M▼ 70.7% | -20.71M▼ 13.2% | -24.05M▼ 16.1% | -21.64M▲ 10.0% | -21.68M▲ 0% |
Net Margin % | -18.9% | 0.4% | -15.89% | -24.96% | -30.6% | -64.99% | -77.37% | -89.33% | -66.85% | -69.5% |
Net Income Growth % | -11.36% | 101.98% | -4032.38% | -44.76% | -61.23% | -70.7% | -13.24% | -16.09% | 9.99% | 14.51% |
Net Income (Continuing) | -5.89M | 116.76K | -4.59M | -6.65M | -10.72M | -18.29M | -20.71M | -24.05M | -21.64M | -21.68M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.26▲ 0% | 0.00▲ 100.8% | -0.07▼ 3150.0% | -0.11▼ 63.9% | -0.16▼ 45.5% | -0.26▼ 62.5% | -0.27▼ 3.8% | -0.30▼ 11.1% | -0.25▲ 16.7% | -0.22▲ 0% |
EPS Growth % | -8.33% | 100.85% | - | -63.93% | -45.45% | -62.5% | -3.85% | -11.11% | 16.67% | 20.97% |
EPS (Basic) | -0.26 | 0.00 | -0.07 | -0.11 | -0.16 | -0.26 | -0.27 | -0.30 | -0.25 | - |
Diluted Shares Outstanding | 22.61M | 52.08M | 63.05M | 72.75M | 75.56M | 76.06M | 80.7M | 85.18M | 90.96M | 98.89M |
Basic Shares Outstanding | 22.61M | 52.08M | 63.05M | 72.75M | 75.56M | 76.06M | 80.7M | 85.18M | 90.96M | 98.89M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
STXS Balance Sheet
Stereotaxis, Inc. (STXS) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 9.87M | 17.97M | 38.83M | 52.72M | 51.39M | 43.25M | 33.27M | 26.44M | 33.85M | 35.83M |
Cash & Short-Term Investments | 3.69M | 10.8M | 30.18M | 43.94M | 38.74M | 28.43M | 19.82M | 12.22M | 13.42M | 14.62M |
Cash Only | 3.69M | 10.8M | 30.18M | 43.94M | 38.74M | 8.59M | 19.82M | 12.22M | 13.42M | 14.62M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 19.84M | 0 | 0 | 0 | 0 |
Accounts Receivable | 4.29M | 5.02M | 5.33M | 3.52M | 5.41M | 5.09M | 3.82M | 3.82M | 5.85M | 9.62M |
Days Sales Outstanding | 50.25 | 62.45 | 67.31 | 48.18 | 56.34 | 66.01 | 52.11 | 51.85 | 65.92 | 73.69 |
Inventory | 1.15M | 1.19M | 1.85M | 3.3M | 4.43M | 7.88M | 8.43M | 8.33M | 9.57M | 10.49M |
Days Inventory Outstanding | 38.93 | 76.08 | 109.89 | 156.94 | 137.25 | 297.07 | 258.21 | 246.74 | 228.14 | 252.42 |
Other Current Assets | 0 | 0 | 0 | 250.62K | 570K | 525K | 623K | 1.28M | 5.01M | 1.1M |
Total Non-Current Assets | 796.59K | 542.06K | 4.75M | 2.74M | 9.6M | 10.17M | 8.64M | 20.29M | 18.4M | 18.2M |
Property, Plant & Equipment | 592.69K | 343.69K | 4.54M | 2.43M | 8.37M | 9.21M | 8.29M | 9.06M | 7.93M | 7.72M |
Fixed Asset Turnover | 52.55x | 85.39x | 6.37x | 10.96x | 4.19x | 3.05x | 3.23x | 2.97x | 4.08x | 3.86x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.76M | 3.76M | 3.76M |
Intangible Assets | 159.47K | 0 | 0 | 0 | 0 | 0 | 0 | 7.36M | 6.43M | 6.19M |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 219K | 0 | 0 | 0 |
Other Non-Current Assets | 44.43K | 198.37K | 218.1K | 308.51K | 1.23M | 952K | 137K | 107K | 278K | 530K |
Total Assets | 10.67M▲ 0% | 18.51M▲ 73.6% | 43.58M▲ 135.4% | 55.46M▲ 27.2% | 60.98M▲ 10.0% | 53.41M▼ 12.4% | 41.91M▼ 21.5% | 46.72M▲ 11.5% | 52.25M▲ 11.8% | 54.03M▲ 0% |
Asset Turnover | 2.92x | 1.59x | 0.66x | 0.48x | 0.57x | 0.53x | 0.64x | 0.58x | 0.62x | 0.65x |
Asset Growth % | -49.12% | 73.57% | 135.41% | 27.24% | 9.97% | -12.42% | -21.54% | 11.49% | 11.83% | 33.87% |
Total Current Liabilities | 30.13M | 10.19M | 12.16M | 13.57M | 13.26M | 14.29M | 13.25M | 21.6M | 22.36M | 23.09M |
Accounts Payable | 1.65M | 1.73M | 2.1M | 1.61M | 4.19M | 3.27M | 3.19M | 5.67M | 4.77M | 4.82M |
Days Payables Outstanding | 56.14 | 110.22 | 124.86 | 76.61 | 129.7 | 123.34 | 97.75 | 167.87 | 113.7 | 133.14 |
Short-Term Debt | 0 | 0 | 0 | 1.19M | 0 | 0 | 0 | 0 | 642K | 662K |
Deferred Revenue (Current) | 5.7M | 5.83M | 5.09M | 5.28M | 6.28M | 7.34M | 7.7M | 7.85M | 5.67M | 18.06M |
Other Current Liabilities | 19.57M | 0 | 0 | 157.62K | 0 | 163K | 0 | 4.59M | 11.28M | 11.06M |
Current Ratio | 0.33x | 1.76x | 3.19x | 3.88x | 3.87x | 3.03x | 2.51x | 1.22x | 1.51x | 1.55x |
Quick Ratio | 0.29x | 1.65x | 3.04x | 3.64x | 3.54x | 2.47x | 1.88x | 0.84x | 1.09x | 1.10x |
Cash Conversion Cycle | 33.03 | 28.31 | 52.34 | 128.51 | 63.9 | 239.74 | 212.56 | 130.72 | 180.36 | 192.97 |
Total Non-Current Liabilities | 1.15M | 1.05M | 2.9M | 1.65M | 8.3M | 7.19M | 6.74M | 13.69M | 11.17M | 11.35M |
Long-Term Debt | 0 | 0 | 0 | 973.25K | 0 | 0 | 0 | 0 | 4.79M | 0 |
Capital Lease Obligations | 0 | 0 | 2.09M | 0 | 5.84M | 5.49M | 5.06M | 5.44M | 0 | 19.49M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 535.37K | 641.46K | 255.52K | 131.23K | 218K | 51K | 43K | 6.19M | 5.82M | 6.21M |
Total Liabilities | 31.27M | 11.24M | 15.06M | 15.23M | 21.56M | 21.48M | 19.99M | 35.29M | 33.53M | 34.43M |
Total Debt | 0 | 0 | 4.34M | 4.45M | 6.11M | 5.86M | 5.49M | 6.01M | 5.44M | 5.28M |
Net Debt | -3.69M | -10.8M | -25.84M | -39.49M | -32.63M | -2.73M | -14.33M | -6.21M | -7.99M | -9.34M |
Debt / Equity | - | - | 0.15x | 0.11x | 0.15x | 0.18x | 0.25x | 0.53x | 0.29x | 0.27x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.27x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.47x |
Interest Coverage | -32.92x | -148.32x | - | - | -1279.71x | - | - | - | - | - |
Total Equity | -20.61M▲ 0% | 7.27M▲ 135.3% | 28.52M▲ 292.3% | 40.23M▲ 41.0% | 39.42M▼ 2.0% | 31.93M▼ 19.0% | 21.92M▼ 31.3% | 11.43M▼ 47.8% | 18.72M▲ 63.8% | 19.6M▲ 0% |
Equity Growth % | -32.7% | 135.29% | 292.27% | 41.03% | -2% | -19.01% | -31.35% | -47.85% | 63.76% | 114.83% |
Book Value per Share | -0.91 | 0.14 | 0.45 | 0.55 | 0.52 | 0.42 | 0.27 | 0.13 | 0.21 | 0.20 |
Total Shareholders' Equity | -20.61M | 7.27M | 28.52M | 40.23M | 39.42M | 31.93M | 21.92M | 11.43M | 18.72M | 19.6M |
Common Stock | 22.81K | 59.06K | 68.53K | 73.69K | 75K | 75K | 81K | 85K | 95K | 97K |
Retained Earnings | -477.13M | -476.72M | -481.31M | -487.96M | -498.68M | -516.97M | -537.68M | -561.73M | -583.37M | -589.23M |
Treasury Stock | -206K | -206K | -206K | -206K | -206K | -206K | -206K | -206K | -206K | -206K |
Accumulated OCI | -5.96M | -5.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
STXS Cash Flow Statement
Stereotaxis, Inc. (STXS) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -4.67M | -2.55M | -4.62M | -3.51M | -2.95M | -8.41M | -9.14M | -8.5M | -13.69M | -15.35M |
Operating CF Margin % | -15.01% | -8.68% | -15.97% | -13.19% | -8.41% | -29.9% | -34.14% | -31.57% | -42.27% | - |
Operating CF Growth % | 28.77% | 45.52% | -81.29% | 23.93% | 16.11% | -185.64% | -8.6% | 7.02% | -61.06% | -524.99% |
Net Income | -5.89M | 116.76K | -4.59M | -6.65M | -10.72M | -18.29M | -20.71M | -24.05M | -21.64M | -21.68M |
Depreciation & Amortization | 753.68K | 579.02K | 122.74K | 126.21K | 106K | 429K | 595K | 969K | 1.55M | 1.19M |
Stock-Based Compensation | 768.68K | 560.97K | 1.33M | 3.17M | 9.36M | 10.58M | 10.62M | 10.26M | 9.85M | 4.81M |
Deferred Taxes | 3.84M | -2.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 100K | 24.66K | 2.34M | 2.34M | -1.83M | -25K | -256K | 1.81M | 2.17M | 7.42M |
Working Capital Changes | -4.24M | -1.65M | -3.82M | -2.5M | 135K | -1.1M | 612K | 2.5M | -5.62M | -7.1M |
Change in Receivables | 378.7K | -733.86K | -308.47K | 1.81M | -1.89M | 316K | 1.27M | 691K | -2.02M | -980K |
Change in Inventory | 285.41K | -365.14K | -655.86K | -1.45M | -1.14M | -2.91M | -550K | 677K | -1.24M | -683K |
Change in Payables | -968.91K | 72.26K | 372.74K | -490.46K | 1.43M | -169K | 218K | 758K | -880K | -1.78M |
Cash from Investing | -81.58K | -265.48K | -29.49K | -70.9K | -1.4M | -22.09M | 19.77M | 74K | -93K | -172K |
Capital Expenditures | -81.58K | -265.48K | -29.49K | -70.9K | -1.4M | -2.38M | -366K | -34K | -93K | -172K |
CapEx % of Revenue | 0.26% | 0.9% | 0.1% | 0.27% | 3.99% | 8.45% | 1.37% | 0.13% | 0.29% | 0.55% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 108K | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | -58.95K | 9.92M | 24.03M | 17.34M | 547K | 220K | 81K | 297K | 14.76M | 19.45M |
Debt Issued (Net) | 0 | 0 | 0 | 2.16M | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 41.05K | 57.14K | 24.03M | 15.18M | 547K | 220K | 81K | 297K | 14.76M | 19.45M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -100K | 9.86M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change in Cash | -4.82M▲ 0% | 7.11M▲ 247.7% | 19.39M▲ 172.7% | 13.76M▼ 29.0% | -3.8M▼ 127.6% | -30.29M▼ 697.9% | 10.71M▲ 135.3% | -8.13M▼ 175.9% | 985K▲ 112.1% | 3.93M▲ 0% |
Free Cash Flow | -4.76M▲ 0% | -2.81M▲ 40.9% | -4.65M▼ 65.2% | -3.58M▲ 22.9% | -4.34M▼ 21.2% | -10.79M▼ 148.5% | -9.51M▲ 11.9% | -8.53M▲ 10.2% | -13.78M▼ 61.5% | -15.52M▲ 0% |
FCF Margin % | -15.27% | -9.58% | -16.08% | -13.45% | -12.4% | -38.35% | -35.5% | -31.69% | -42.55% | -49.75% |
FCF Growth % | 31.79% | 40.88% | -65.22% | 22.89% | -21.22% | -148.51% | 11.93% | 10.25% | -61.51% | -94.88% |
FCF per Share | -0.21 | -0.05 | -0.07 | -0.05 | -0.06 | -0.14 | -0.12 | -0.10 | -0.15 | -0.16 |
FCF Conversion (FCF/Net Income) | 0.79x | -21.81x | 1.01x | 0.53x | 0.27x | 0.46x | 0.44x | 0.35x | 0.63x | 0.72x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
STXS Key Ratios
Stereotaxis, Inc. (STXS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | 1.61% | -25.65% | -19.33% | -26.91% | -51.27% | -76.93% | -144.19% | -143.55% | -153.21% |
Return on Invested Capital (ROIC) | - | - | - | -294.83% | -256.68% | -78.23% | -89.03% | -289.62% | -207.86% | -193.51% |
Gross Margin | 65.47% | 80.52% | 78.77% | 71.22% | 66.34% | 65.62% | 55.51% | 54.22% | 52.73% | 53.86% |
Net Margin | -18.9% | 0.4% | -15.89% | -24.96% | -30.6% | -64.99% | -77.37% | -89.33% | -66.85% | -69.5% |
Debt / Equity | - | - | 0.15x | 0.11x | 0.15x | 0.18x | 0.25x | 0.53x | 0.29x | 0.27x |
Interest Coverage | -32.92x | -148.32x | - | - | -1279.71x | - | - | - | - | - |
FCF Conversion | 0.79x | -21.81x | 1.01x | 0.53x | 0.27x | 0.46x | 0.44x | 0.35x | 0.63x | 0.72x |
Revenue Growth | -3.17% | -5.77% | -1.51% | -7.86% | 31.51% | -19.63% | -4.89% | 0.55% | 20.28% | 13.4% |
Related:STXS Dividend History·STXS Revenue History·STXS Price History·STXS P/E History·STXS Financial Ratios·STXS Institutional Holders
STXS SEC Filings & Documents
Stereotaxis, Inc. (STXS) SEC filings — annual & quarterly reports (10-K, 10-Q)
STXS Frequently Asked Questions
Stereotaxis, Inc. (STXS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Stereotaxis, Inc. (STXS) reported $31.2M in revenue for fiscal year 2025. This represents a 164953% increase from $0.0M in 2002.
Stereotaxis, Inc. (STXS) grew revenue by 20.3% over the past year. This is strong growth.
Stereotaxis, Inc. (STXS) reported a net loss of $21.7M for fiscal year 2025.
Dividend & Returns
Stereotaxis, Inc. (STXS) has a return on equity (ROE) of -143.6%. Negative ROE indicates the company is unprofitable.
Stereotaxis, Inc. (STXS) had negative free cash flow of $15.5M in fiscal year 2025, likely due to heavy capital investments.